Core Laboratories price target raised to $25 from $24 at Stifel

Stifel raised the firm’s price target on Core Laboratories to $25 from $24 and keeps a Hold rating on the shares. The company’s Q1 revenue and EBITDA exceeded the firm’s expectations, which was driven by stronger-than-expected performance in both segments, the analyst tells investors. Rising international activity bodes well for the RD segment and Stifel expects revenue and margins will likely increase for the balance in 2023.